FINWIRES · TerminalLIVE
FINWIRES

India Reportedly Allows Iranian Oil Tankers to Dock Amid Supply Disruptions

-- India has reportedly allowed four Iranian oil tankers to dock, signaling a rare easing of restrictions for Iranian crude, according to multiple media reports.

The shipping ministry granted permission for vessels carrying Iranian crude to berth at Sikka port following a request from Reliance Industries, according to reports.

India, the world's third-largest oil importer, had halted Iranian crude purchases in 2019 under US pressure.

The move follows a temporary US waiver issued last month permitting limited transactions involving Iranian oil at sea to help stabilize global prices.

The exemption is set to expire on Apr. 19, creating urgency for importers seeking to secure alternative supplies during heightened geopolitical tensions.

Iranian shipments are typically transported by vessels lacking standard insurance and certifications, requiring special government approval under Indian maritime regulations.

The approved vessels include Aframax tanker Kaviz and very large crude carriers Lenore, Felicity, and Hedy, all of which are under US sanctions.

Each supertanker can carry up to 2 million barrels of crude, offering significant potential volumes if the cargoes are processed.

Tracking data showed some vessels positioned near Iran's Chabahar port in early April, while others recently loaded cargoes or exited the Gulf, the report said.

Despite the approvals, it remains uncertain whether Reliance will refine the oil, as the company is assessing compliance with sanctions and domestic regulations.

Separately, Indian Oil has already received Iranian crude via a sanctioned tanker, indicating limited resumption of flows under exceptional circumstances.

India's Ministry of Ports, Shipping and Waterways and Reliance did not immediately respond to' request for comment.

相關文章

Asia

Dizal Pharma將在美國臨床腫瘤學會年會上發表三種藥物的研究成果。

根據週三在上海證券交易所發布的公告顯示,江蘇迪扎爾製藥(SHA:688192)表示,將在美國臨床腫瘤學會(ASCO)年會上公佈其新藥sunvozertinib片劑、golidocitinib膠囊和DZD6008的最新研究成果。 sunvozertinib和DZD6008皆用於治療非小細胞肺癌,而golidocitinib則用於治療T細胞淋巴瘤。研究結果顯示,這些藥物均取得了正面成果,尤其是DZD6008,其具有顯著的抗腫瘤活性且安全性良好。 該生技公司的股價在午盤交易中上漲不到2%。

$SHA:688192
Asia

Critica將於3月季度啟動西澳大利亞稀土計畫範圍界定研究。

根據週三提交給澳洲證券交易所的文件顯示,Critica(ASX:CRI)表示,位於西澳大利亞的Jupiter稀土計畫的初步研究已於今年3月季度正式啟動。 該研究整合了選礦、下游加工、基礎設施和開發假設,旨在確定一個基準開發路徑。 公司計劃在6月季度繼續完成Jupiter專案140個鑽孔的資源升級鑽探工作。此外,該公司還計劃準備並運送20,000公斤散裝樣品進行中試規模處理,以支援持續的最佳化、性能提升和中間精礦的生產。

$ASX:CRI
Asia

北太平洋銀行的收購要約確保了對卡里爾銀行的控制權

北太平洋銀行(東京證券交易所代號:8524)週三在東京證券交易所發佈公告稱,其對Career Bank的股份收購要約已獲成功,持股比例增至88.26%,使Career Bank成為其子公司。 北太平洋銀行此次收購了852,487股Career Bank股份,超過了完成交易所需的最低收購數量。 交易結算將於4月28日開始,屆時Career Bank將正式併入北太平洋銀行的財務報表。 北太平洋銀行計劃啟動相關程序,使Career Bank成為其全資子公司,並將其股票從札幌證券交易所下市。此次收購總成本約為15億日圓。

$TYO:8524